Zusätzliche Beschreibung:
SYLOID® FP mesoporous silica's distinctive morphology makes it well suited to pharmaceutical formulations, improving powder handling, adsorption and dissolution; it functions as an effective moisture-sensitive-API desiccant, a powder-suspension conditioner, a capillary wetting agent for improved release and disintegration, and a contributor to controlled API release, all while remaining low-dusting and easy to handle. SYLOID® XDP silica is engineered to convert liquids, particularly oily actives and lipid-based systems, into free-flowing solids, acting as a solid carrier for lipid-based delivery systems that boosts bioavailability, increases API loading in solid dosage forms, enables fast, complete API release, and supports liquisolid formulation development. VYVID™ superparamagnetic silica rounds out the portfolio with additional magnetic-particle capabilities.
Bewertung & Kommentar hinterlassen